Prospective sampling, multicenter study to investigate clinical data and intestinal environment of patients with unexplained abdominal symptoms to explore the association with treatment efficacy and prognosis.
Not Applicable
Recruiting
- Conditions
- The patients with unexplained abdominal symptoms
- Registration Number
- JPRN-UMIN000051617
- Lead Sponsor
- International university of health and welfare Narita hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who cannot give their consent to participate in this study. Patients who are unable to collect specimens due to defecation problems.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total bile acid concentration in stool
- Secondary Outcome Measures
Name Time Method Biochemical markers (TP, Alb, AST, ALT, GTP, BUN, Cre, UA, CRP, TG, T-cho, LDL-C, endotoxin, various antibodies, various vitamins, etc.) -Hematological examination (WBC, Hb, Plt, PT, APTT, erythrocyte sedimentation rate, etc.) -Blood metabolome analysis -Hydrogen breath test Lactulose-mannitol test Imaging findings (abdominal x-ray with Schitzmark, abdominal ultrasound, abdominal CT, Cine-MRI, endoscopic findings, etc.) -Pathological findings -Stool metabolome analysis, organic acid analysis -Bile metabolome analysis -Urinary metabolome analysis -Clinical findings, history, complications, and medication history -Questionnaire/Questionnaire -Fecal microbiota analysis